Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hinson KRW, Moon A, Plummer NS. Broncho-pulmonary aspergillosis: a review and a report of eight new cases. Thorax 1952; 7: 317–333.
Pepys J, Riddell RW, Citron KM, Clayton YM, Short EI. Clinical and immunologic significance of Aspergillus fumigatus in the sputum. Am Rev Respir Dis 1959: 80: 167–180.
Scadding JG. Bronchi in allergic aspergillosis. Scand J Respir Dis 1967; 48: 372–377.
Golbert TM, Patterson R. Pulmonary allergic aspergillosis. Ann Intern Med 1970; 72: 395–403.
Bernton HS. Asthma due to a mold-Aspergillus fumigatus. JAMA 1930; 95: 189–191.
Feinberg SM. Allergy to fungi, in Allergy in Practice. ( Feinberg SM, eds.), Chicago: The Year Book, 1946, pp. 216–220.
Austwick PKC. Pathogenicity, in The Genus Aspergillus. ( Raper KB, Fennell DI, eds.), Huntington, NY, Robert E. Krieger, 1977, pp. 94.
Bardana EJ. The clinical spectrum of aspergillosis-Part 1: Epidemiology, pathogenicity, infection in animals and immunology of Aspergillus. CRC Crit Rev Clin Lab Sci 1980; 13: 21–83.
Sinski JT. The epidemiology of aspergillosis, in The Epidemiology of Human Mycotic Diseases. ( Al-Doory Y, ed.), Springfield IL: Charles Thomas, 1975, pp. 217–226.
Novey HS, Wells ID. Allergic bronchopulmonary aspergillosis caused by Aspergillus ochraceus. Am J Clin Pathol 1978; 70: 840–844.
Campbell MJ, Clayton YM. Bronchopulmonary aspergillosis: a correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis. Am Rev Respir Dis 1964; 89: 186–196.
McCarthy DS, Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology: (1) Clinical features. Clin Allergy 1971; 1: 261–286.
Novey HS. Epidemiology of allergic bronchopulmonary aspergillosis. Immunol Allergy Clin NAm 1998; 18: 641–653.
Basich JE, Graves TS, Baz MN, et al. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol 1981; 68: 98–102.
Lynch DA. Imaging of asthma and allergic bronchopulmonary mycosis. Radiol Clin NAm 1998; 36: 129–142.
Tamura A, Hebisawa A, Kurashima A, et al. The use of bronchofiberscopy for diagnosis of allergic bronchopulmonary aspergillosis. Intern Med 1997; 36: 865–869.
Mintzer RA, Rogers LF, Kruglik GD, et al. The spectrum of radiologic findings in allergic bronchopulmonary aspergillosis. Radiology 1978; 127: 301–307.
Symmers WC. Histological aspects of the pathogenesis of some opportunistic fungal infections, as exemplified in the pathology of aspergillosis and the phycomycetoses. Lab Invest 1962; 11: 1073–1090.
Riley DJ, Mackenzie JW, Uhlman WE, et al. Allergic bronchopulmonary aspergillosis: evidence of limited tissue invation. Amer Rev Respir Dis 1975; 111: 232–236.
Katzenstein AL, Liebow AA, Friedman PJ. Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungus. Amer Rev Respir Dis 1975; 111: 497–537.
Trompelt J, Becker WM, Schlaak M. Analysis of IgG subclass and IgE response in allergic disease caused by Aspergillus fumigatus by immunoblotting techniques. Int Arch Allergy Immunol 1994; 104: 390–398.
Kurup VP, Grunig G, Knutsen AP, Murali PS. Cytokines in allergic bronchopulmonary aspergillosis. Res Immunol 1998; 149: 466–77, 515–516.
Slavin RG, Hutchins PS, Knutsen AP. Participation of cell-mediated immunity in allergic bronchopulmonary aspergillosis. Int Arch Allergy Appl Immunol 1987; 83: 337–340.
Amitani R, Taylor G, Elezis EN, et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 1995; 63: 3266–3271.
Chauhan B, Santiago L, Kirschmann DA, et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. Jlmmunol 1997; 159: 4072–4075.
Vaughan LM. Allergic bronchopulmonary aspergillosis. Clin Pharm 1993; 12: 24–33.
Schwartz HJ, Stevens DA, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. New Eng J Med 2000; 256.
Wang JL, Patterson R, Roberts M, et al. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1979; 120: 87–91.
Crompton GK. Inhaled beclomethasone diproprionate in allergic bronchopulmonary aspergillosis: report to the research committee of the British Thoracic Association. Br J Dis Chest 1979; 73: 349–356.
Safirstein BH, D’ Souza MF, Simon G, et al. Five year follow-up of bronchopulmonary aspergillosis. Am Rev Respir Dis 1973; 108: 450–479.
Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1984; 74: 68–71.
Sandhu RS, Mehta SK, Khan ZU, Singh MM. Role of Aspergillus and Candida species in allergic bronchopulmonary mycoses: a comparative study. Scand J Resp Dis 1979; 60: 235–242.
Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum. Am J Respir Crit Care Med 1995; 152: 1379–1381.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Novey, H.S. (2001). Allergic Bronchopulmonary Aspergillosis. In: Gershwin, M.E., Albertson, T.E. (eds) Bronchial Asthma. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-127-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-59259-127-5_14
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-4687-7
Online ISBN: 978-1-59259-127-5
eBook Packages: Springer Book Archive